Southeast Asia: COVID-19 activity in Southeast Asia continues through April. /update 9

Event

Several countries and territories in Southeast Asia continue to report COVID-19 transmission in April. According to World Health Organization (WHO) data through April 12, the following countries and territories in Southeast Asia have identified confirmed COVID-19 cases:

Sporadic cases:

• Bhutan: 921 cases

Clusters of cases:

• India: 13,521,409 cases*

• Nepal: 280,524 cases*

• Myanmar: 142,212 cases

• Sri Lanka: 95,131 cases*

• Thailand: 33,610 cases*

• Maldives: 25,701 cases

• Timor-Leste: 1,046 cases*

Community transmission

• Indonesia: 1,566,995 cases

• Bangladesh: 691,957 cases

*As of April 12, active cases in the country are increasing.

Additional cases may be added to this list at any time as disease surveillance and testing continues.

Context

COVID-19 is a viral respiratory disease caused by infection with the SARS-CoV-2 virus. Human-to-human transmission does occur, primarily through respiratory droplets from infected individuals or contact with contaminated surfaces or objects. Symptoms occur 1-14 days following exposure (average of 3-7 days). These symptoms typically include fever, fatigue, and dry cough; less common symptoms include headache, diarrhea, loss of taste or smell, reddening of the eyes, skin rash, or discoloration of the fingers or toes. Symptoms may worsen to difficulty breathing, pneumonia, and organ failure - especially in those with underlying, chronic medical conditions. Some infected individuals display no symptoms. Multiple variants of COVID-19 have been identified globally, some of which spread more easily between people. COVID-19 vaccines are being distributed to frontline workers and the elderly in some countries, while other vaccines are in varying stages of development and clinical trials; more data is required to determine the efficacy of vaccines against COVID-19 variants.

Older individuals and people of any age with chronic medical conditions or compromised immunity should consider postponing nonessential travel, including domestic travel, and take special precautions to avoid becoming ill, especially where sustained community transmission of COVID-19 is ongoing. All individuals should monitor their health and limit interactions with others for 14 days after returning from travel.

Advice

Emphasize basic health precautions, especially frequent handwashing with soap and water, or an alcohol-based hand sanitizer if soap and water are unavailable. Practice good coughing/sneezing etiquette (i.e., covering coughs and sneezes with a disposable tissue, maintaining distance from others, and washing hands). There is no evidence that the influenza vaccine, antibiotics, or antiviral medications will prevent this disease, highlighting the importance of diligent basic health precautions.

Resources

WHO coronavirus knowledge base
WHO: Public health considerations while resuming international travel
US CDC: Guidance for Businesses and Workplaces
US CDC: Preventing COVID-19 Spread in Communities
Mental Health Considerations during COVID-19 Outbreak
US CDC: Manage Anxiety and Stress
New England Journal of Medicine: COVID Vaccine Frequently Asked Questions